1. A new dopaminergic nigro-olfactory projection
- Author
-
Vincent Ries, Günter U. Höglinger, Andreas Borta, Rainer K.W. Schwarting, Ursula Keber, Wolfgang H. Oertel, Dieter Scheller, Miriam Djufri, Oscar Arias-Carrión, Daniel Alvarez-Fischer, and Andrea Windolph
- Subjects
Male ,drug effects [Olfactory Bulb] ,Olfactory system ,drug effects [Neural Stem Cells] ,Dopamine ,metabolism [Olfaction Disorders] ,metabolism [Neural Stem Cells] ,pathology [Neural Stem Cells] ,drug effects [Neurogenesis] ,pathology [Parkinsonian Disorders] ,Olfaction Disorders ,pathology [Olfactory Bulb] ,chemistry.chemical_compound ,Neural Stem Cells ,Neural Pathways ,pathology [Neurons] ,pharmacology [Thiophenes] ,metabolism [Dopamine] ,Neurons ,metabolism [Olfactory Bulb] ,Dopaminergic ,pathology [Neural Pathways] ,Anatomy ,physiology [Neurogenesis] ,Olfactory Bulb ,Immunohistochemistry ,Substantia Nigra ,Neuroanatomical Tract-Tracing Techniques ,pharmacology [Dopamine Agonists] ,pharmacology [Tetrahydronaphthalenes] ,metabolism [Neurons] ,Dopamine Agonists ,metabolism [Neural Pathways] ,pathology [Olfaction Disorders] ,Oxidopamine ,Tetrahydronaphthalenes ,Neurogenesis ,drug therapy [Olfaction Disorders] ,metabolism [Parkinsonian Disorders] ,Substantia nigra ,Thiophenes ,Olfaction ,Biology ,Pathology and Forensic Medicine ,Cellular and Molecular Neuroscience ,Parkinsonian Disorders ,drug therapy [Parkinsonian Disorders] ,metabolism [Substantia Nigra] ,Animals ,drug effects [Neurons] ,ddc:610 ,Rats, Wistar ,Olfactory memory ,Neuronal Tract-Tracers ,pathology [Substantia Nigra] ,drug effects [Neural Pathways] ,Olfactory tubercle ,rotigotine ,Olfactory bulb ,nervous system ,chemistry ,drug effects [Substantia Nigra] ,Neurology (clinical) ,Neuroscience - Abstract
Parkinson disease (PD) is a neurodegenerative disorder characterized by massive loss of midbrain dopaminergic neurons. Whereas onset of motor impairments reflects a rather advanced stage of the disorder, hyposmia often marks the beginning of the disease. Little is known about the role of the nigro-striatal system in olfaction under physiological conditions and the anatomical basis of hyposmia in PD. Yet, the early occurrence of olfactory dysfunction implies that pathogens such as environmental toxins could incite the disease via the olfactory system. In the present study, we demonstrate a dopaminergic innervation from neurons in the substantia nigra to the olfactory bulb by axonal tracing studies. Injection of two dopaminergic neurotoxins-1-methyl-4-phenylpyridinium and 6-hydroxydopamine-into the olfactory bulb induced a decrease in the number of dopaminergic neurons in the substantia nigra. In turn, ablation of the nigral projection led to impaired olfactory perception. Hyposmia following dopaminergic deafferentation was reversed by treatment with the D1/D2/D3 dopamine receptor agonist rotigotine. Hence, we demonstrate for the first time the existence of a direct dopaminergic projection into the olfactory bulb and identify its origin in the substantia nigra in rats. These observations may provide a neuroanatomical basis for invasion of environmental toxins into the basal ganglia and for hyposmia as frequent symptom in PD.
- Published
- 2015
- Full Text
- View/download PDF